Larson Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Buy
1,039
+115
+12% +$24.4K 0.01% 886
2026
Q2
$200K Buy
924
+43
+5% +$8.23K 0.01% 849
2026
Q1
$162K Buy
881
+206
+31% +$38K 0.01% 788
2025
Q4
$119K Buy
675
+37
+6% +$6.04K ﹤0.01% 872
2025
Q3
$89.4K Buy
638
+121
+23% +$16.4K ﹤0.01% 947
2025
Q2
$64.9K Buy
517
+436
+538% +$54.3K ﹤0.01% 976
2025
Q1
$11.1K Sell
81
-82
-50% -$11.7K ﹤0.01% 1593
2024
Q4
$24.9K Buy
163
+141
+641% +$23.8K ﹤0.01% 1138
2024
Q3
$4.26K Sell
22
-464
-95% -$97.1K ﹤0.01% 1700
2024
Q2
$113K Buy
486
+277
+133% +$60.2K 0.01% 618
2024
Q1
$45.1K Buy
209
+173
+481% +$40.5K ﹤0.01% 713
2023
Q4
$9.32K Hold
36
– – ﹤0.01% 1038
2023
Q3
$9.25K Hold
36
– – ﹤0.01% 1019
2023
Q2
$10.3K Sell
36
-87
-71% -$25.9K ﹤0.01% 924
2023
Q1
$34.2K Sell
123
-8
-6% -$2.21K ﹤0.01% 623
2022
Q4
$36.3K Buy
131
+38
+41% +$10.7K ﹤0.01% 581
2022
Q3
$25K Buy
+93
New +$19.8K ﹤0.01% 576
2021
Q4
– Sell
-77
Closed -$22K – 1075
2021
Q3
$22K Hold
77
– – ﹤0.01% 442
2021
Q2
$27K Buy
+77
New +$23.3K 0.01% 385
2020
Q1
– Sell
-4
Closed -$1K – 543
2019
Q4
$1K Hold
4
– – ﹤0.01% 490
2019
Q3
$1K Hold
4
– – ﹤0.01% 469
2019
Q2
$1K Hold
4
– – ﹤0.01% 422
2019
Q1
$1K Hold
4
– – ﹤0.01% 417
2018
Q4
$1K Buy
+4
New +$1.28K ﹤0.01% 392

Other funds holding BIIB

Larson Financial Group's BIIB Position: Q3 2026 in Review

Larson Financial Group increased its Biogen (BIIB) stake by 12% in Q3 2026, buying an estimated $24.4K and bringing the position to 1,039 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #886.

Larson Financial Group first reported a position in BIIB in Q4 2018 and has held it in 24 quarters since. 1,058 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Larson Financial Group held 1,039 shares of Biogen worth $235K as of Q3 2026.
  • Larson Financial Group bought 115 Biogen shares in Q3 2026, an estimated $24.4K.
  • Biogen made up 0.01% of Larson Financial Group's portfolio in Q3 2026, its #886 holding.
  • Larson Financial Group first reported a position in Biogen in Q4 2018 and has held it in 24 quarters since.
  • 1,058 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.